PHAT Operating Expenses

Phathom Pharmaceuticals Inc · Operating Expenses

PHAT logo

PHAT Operating Expenses

Latest reported$239.37M
PHAT TTM Operating Expenses ($1.23M → $239.37M)
High-resolution chart · PNG

PHAT operating expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Phathom Pharmaceuticals Inc Operating Expenses — Trailing twelve months (TTM) (USD)
Period endingOperating Expenses (USD)
239,374,000
270,620,000
312,496,000
341,898,000
368,105,000
356,964,000
324,746,000
309,684,000
260,430,000
208,883,000
167,520,000
143,790,000
150,606,000
164,268,000
171,969,000
158,535,000
149,318,000
139,274,000
135,080,000
154,479,000
154,172,000
138,874,000
125,665,000
88,919,000
62,371,000
125,364,000
106,215,000
90,973,000
84,959,000
2,198,000
1,225,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.